Skip to content
Disclosery

EXANE DERIVATIVES: SAIA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SAIA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 0 SAIA shares at 2022-03-31 per its 13F-HR filed 2022-04-22.

the latest 13F is the newest step

  1. period ended2022-03-31
    13F 0 shares
    Change vs previous 13F -144 shares

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2021-12-31
    13F 144 shares
    Change vs previous 13F -125 shares

    0.01% of the 13F portfolio, value $48,531.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-09-30
    13F 269 shares
    Change vs previous 13F -48 shares

    0.02% of the 13F portfolio, value $64,028.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 317 shares
    Change vs previous 13F -1,175 shares

    0.02% of the 13F portfolio, value $65,326.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 1,492 shares
    Change vs previous 13F +67 shares

    0.1% of the 13F portfolio, value $344,010.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2020-12-31
    13F 1,425 shares
    Change vs previous 13F +756 shares

    0.08% of the 13F portfolio, value $257,628.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-09-30
    13F/A 669 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $84,383.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).